leisure time -WSS

leisure time

author：leisure time 2025-09-06 02:04:54 - browse：47673

Ed Silverman on the Breakthrough Summit stage in 2023. — STAT's Ed Silverman on stage at the STAT Breakthrough Summit in 2023. Sarah Gonzalez for STAT

In 2023, STAT launched a brand-new home for our subscribers to connect with each other and with their favorite STAT journalists. On STAT+ Connect, you can find job postings; comment on STAT articles (since we have closed comments on article pages); discuss industry events with other people who work in biotech, pharma, public health advocacy, PR, and more; read insights and exclusive material posted by STAT reporters and editors; and watch events, including live interviews and text-based Ask Me Anything chats.

Last week, Ed Silverman, AKA Pharmalot, hosted an AMA titled “Stump Pharmalot.” During the AMA, Ed discussed gene therapy, his proudest career moments, what he took in high school instead of chemistry, coffee (or, as he calls it, “cups of stimulation”), and more.

Below, you can find a lightly edited transcript of the conversation.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： What's changing in Medicare's open enrollment this year?

WSS

Peter Marks talks Operation Warp Speed for Rare Diseases

Massive project maps cells in human brain in unprecedented detail

Bernie Sanders bashes nonprofit hospitals over their tax breaks

Cancer cells are shown to suck energy source from immune cells

A revolution in caring for preterm infants

Change Healthcare outage fallout shows need for new oversight

Wikipedia

leisure time

knowledge

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

UnitedHealth’s Q3 profit jumps as medical costs rise more slowly

Peter Hotez and the public health issue of online harassment

Peter Marks talks Operation Warp Speed for Rare Diseases

Tori Bowie and the unacceptable rates of Black maternal death

Readout Newsletter: Bristol, Sangamo, Gilead, and more

Cancer drug shortages should be causing more outrage

Peter Marks talks Operation Warp Speed for Rare Diseases

Duchenne breakthrough therapy leaves behind pioneering families

John Green on his newest strategy for fighting tuberculosis

entertainment

Readout Newsletter: Bristol, Sangamo, Gilead, and more

Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline

How to save health care price transparency rules

How clinical AI models' predictive power can degrade over time

Male and female sex labels in research insufficient, scientists say

Boston's new lab space is opening empty

focus

entertainment

knowledge

knowledge